GCISAVE: A Non-Comparative Randomized Phase II Study of Combination of Gemcitabine Cisplatin (gcis) +/- Avelumab (A) in 1st Line Treatment for Locally Advanced or Metastatic Urothelial Bladder Carcinoma (MUBC)—GETUG AFU V07.
Journal of Clinical Oncology（2024）
Key words
261-566-9718-9794,261-492-2769,613-135-244-3829,261-492-5651-9270,3590,176,1880,62,1880,242,295
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined